John Lee
35Patents
18h-index
55Co-inventors
84Inventor score
Filing activity: Aug 19, 1986 → Oct 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6050990A | Methods and devices for inhibiting hair growth and related skin treatments | Human Necessities | 1,661 | Expired |
| US5948428A | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors | Human Necessities | 262 | Expired |
| US5916870A | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors | Human Necessities | 223 | Expired |
| US5854207A | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors | Human Necessities | 212 | Expired |
| US5686455A | Imidazole derivatives and their use as cytokine inhibitors | Chemistry; Metallurgy | 165 | Expired |
| US6048964A | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors | Human Necessities | 158 | Expired |
| US5656644A | Pyridyl imidazoles | Chemistry; Metallurgy | 130 | Expired |
| US6268370A | Compounds | Chemistry; Metallurgy | 95 | Expired |
| US6645989B2 | Compounds | Chemistry; Metallurgy | 86 | Expired |
| US5777097A | Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein | Chemistry; Metallurgy | 63 | Expired |
| US5783664A | Cytokine suppressive anit-inflammatory drug binding proteins | Human Necessities | 59 | Expired |
| US5871934A | Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins | Chemistry; Metallurgy | 57 | Expired |
| US5317019A | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5916891A | Pyrimidinyl imidazoles | Chemistry; Metallurgy | 40 | Expired |
| US5955366A | Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins | Chemistry; Metallurgy | 33 | Expired |
| US7026292B1 | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors | Human Necessities | 29 | Expired |
| US5969184A | Amide compounds | Chemistry; Metallurgy | 24 | Expired |
| US4794114A | Inhibition of interleukin-1 production by monocytes and/or macrophages | Human Necessities | 21 | Expired |
| US4780470A | Inhibition of interleukin-1 by monocytes and/or macrophages | Human Necessities | 12 | Expired |
| US4778806A | Inhibition of interleukin-1 production by monocytes and/or macrophages | Human Necessities | 12 | Expired |
| US6361773B1 | Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins | Human Necessities | 10 | Expired |
| US6150557A | Compounds | Chemistry; Metallurgy | 8 | Expired |
| US6696410B1 | Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors | Human Necessities | 4 | Expired |
| US11254721B2 | GIPR-agonist compounds | Human Necessities | 2 | Active |
| US6103936A | Process of making tosylbenzyl formamide derivatives | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.